Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R&M SCCHN) (EXTREME).

被引：0
|
作者：
Vermorken, J. B.
Mesia, R.
Vega-Villegas, M. E.
Remenar, E.
Hitt, R.
Kawecki, A.
Rottey, S.
Zabolotnyy, D.
Erfan, J.
Amellal, N.
Antwerpen, U. Z.
机构：
[1] UZ Antwerpen, Edegem, Belgium
[2] Hosp Duran I Reynals Inst Catala Oncol, Barcelona, Spain
[3] Hosp Univ Marques Valdecilla, Santander, Spain
[4] Orszagos Onkol Intezet, Budapest, Hungary
[5] Hosp 12 Octubre, E-28041 Madrid, Spain
[6] Klin Nowotworow Glowy & Szyi, Warsaw, Poland
[7] UZ Gent, Ghent, Belgium
[8] Inst Otolaringol AMS Ukraine, Kiev, Ukraine
[9] Szalbolcs Szatmar Bereg Megyei Josa Andras Korhaz, Nyiregyhaza, Hungary
[10] Merck KGaA, Darmstadt, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：289S / 289S
页数：1
相关论文
共 50 条
  • [11] Carboplatin and 5-fluorouracil in squamous cell carcinoma of the head and neck previously responding to cisplatin and 5-fluorouracil
    Benasso, M
    Numico, G
    Merlano, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (02) : 318 - 319
  • [12] Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin Vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial)
    Tsakonas, Georgios
    Specht, Lena
    Kristensen, Claus Andrup
    Moreno, Maria Herlestam Calero
    Haugen Cange, Hedda
    Soderstrom, Karin
    Friesland, Signe
    CANCERS, 2020, 12 (11) : 1 - 11
  • [13] A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Baghi, M
    Hambek, M
    Wagenblast, J
    May, A
    Wolfgang
    Gstoettner
    Knecht, R
    ANTICANCER RESEARCH, 2006, 26 (1B) : 585 - 590
  • [14] A RANDOMIZED TRIAL OF CISPLATIN (CACP) + 5-FLUOROURACIL (5-FU) INFUSION AND CACP + 5-FU BOLUS FOR RECURRENT AND ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    KISH, JA
    ENSLEY, JF
    JACOBS, J
    WEAVER, A
    CUMMINGS, G
    ALSARRAF, M
    CANCER, 1985, 56 (12) : 2740 - 2744
  • [15] Phase Ib Study of Duligotuzumab (MEHD7945A) Plus Cisplatin/5-Fluorouracil or Carboplatin/Paclitaxel for First-Line Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Jimeno, Antonio
    Machiels, Jean-Pascal
    Wirth, Lori
    Specenier, Pol
    Seiwert, Tanguy Y.
    Mardjuadi, Feby
    Wang, Xiaodong
    Kapp, Amy V.
    Royer-Joo, Stephanie
    Penuel, Elicia
    McCall, Bruce
    Pirzkall, Andrea
    Clement, Paul M.
    CANCER, 2016, 122 (24) : 3803 - 3811
  • [16] Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Bourhis, Jean
    Rivera, Fernando
    Mesia, Ricard
    Awada, Ahmad
    Geoffrois, Lionel
    Borel, Christian
    Humblet, Yves
    Lopez-Pousa, Antonio
    Hitt, Ricardo
    Vega Villegas, M. Eugenia
    Duck, Lionel
    Rosine, Dominique
    Amellal, Nadia
    Schueler, Armin
    Harstrick, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2866 - 2872
  • [17] Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
    Takeshita, Naohiro
    Enokida, Tomohiro
    Okano, Susumu
    Fujisawa, Takao
    Wada, Akihisa
    Sato, Masanobu
    Tanaka, Hideki
    Tanaka, Nobukazu
    Onaga, Ryutaro
    Hoshi, Yuta
    Sakashita, Shingo
    Ishii, Genichiro
    Tahara, Makoto
    ORAL ONCOLOGY, 2023, 147
  • [18] Efficacy of Cetuximab Alone or in Combination With Docetaxel as Second-line Treatment in Patients With Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    Fekih, M.
    Ferrand, F. R.
    Saada, E.
    Hamdan, D.
    Desmaris, R.
    Schilf, A.
    Guigay, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S568 - S569
  • [19] A COMPARISON OF CISPLATIN 5-FU WITH CARBOPLATIN 5-FU FOR 5-YEAR SURVIVAL OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    EBELING, O
    ECKEL, HE
    VOLLING, P
    HEITMANN, K
    VOSSING, M
    HNO, 1994, 42 (10) : 629 - 635
  • [20] PREDICTORS OF EFFICACY IN THE EXTREME STUDY: CETUXIMAB PLUS PLATINUM-BASED THERAPY FIRST-LINE IN PATIENTS WITH RECURRENT AND/OR METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
    Vermorken, J. B.
    Mesia, R.
    Remenar, E.
    Erfan, J.
    Zabolotnyy, D.
    Benasso, M.
    Koralewski, P.
    Gross, A.
    Stroh, C.
    Bokemeyer, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 217 - 217
12345